(Q37973223)

English

Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention

scientific article published on 04 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention (English)

1 reference

Europe PubMed Central

26 August 2017

0 references

personalized medicine

1 reference

based on heuristic

inferred from title

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

J H Meyer

1

1 reference

Europe PubMed Central

26 August 2017

language of work or name

0 references

publication date

4 January 2012

1 reference

Europe PubMed Central

26 August 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

26 August 2017

91

1 reference

Europe PubMed Central

26 August 2017

2

1 reference

Europe PubMed Central

26 August 2017

201-214

1 reference

Europe PubMed Central

26 August 2017

https://scigraph.springernature.com/pub.10.1038/clpt.2011.285

0 references

Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The therapeutic potential of monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Applying neuroimaging ligands to study major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Neural mechanisms mediating optimism bias

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The neural basis of loss aversion in decision-making under risk

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated brain monoamine oxidase A binding in the early postpartum period

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Prospective study of postpartum blues. Biologic and psychosocial factors

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Gliogenesis and glial pathology in depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

A hundred cases of suicide: clinical aspects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

An overview of epidemiological studies on seasonal affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Seasonal variation in human brain serotonin transporter binding.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

PET imaging of serotonin 1A receptor binding in depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced serotonin type 1A receptor binding in panic disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced serotonin-1A receptor binding in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Lower dopamine transporter binding potential in striatum during depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Dopamine transporter binding in depressed patients with anhedonia.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Repeated reserpine administration reduces in vivo [18F]GBR 13119 binding to the dopamine uptake site.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Course of illness, hippocampal function, and hippocampal volume in major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Cellular changes in the postmortem hippocampus in major depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

21 January 2018

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain serotonin2 receptors in major depression: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased 5-HT 2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [ 11 C]MDL 100,907

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.285

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2011.285

1 reference

Europe PubMed Central

26 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37973223&oldid=1735191272"